W. E. Bachmann

3.7k total citations
78 papers, 707 citations indexed

About

W. E. Bachmann is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, W. E. Bachmann has authored 78 papers receiving a total of 707 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Surgery, 18 papers in Endocrinology, Diabetes and Metabolism and 12 papers in Genetics. Recurrent topics in W. E. Bachmann's work include Diabetes and associated disorders (11 papers), Nasal Surgery and Airway Studies (11 papers) and Diabetes Management and Research (10 papers). W. E. Bachmann is often cited by papers focused on Diabetes and associated disorders (11 papers), Nasal Surgery and Airway Studies (11 papers) and Diabetes Management and Research (10 papers). W. E. Bachmann collaborates with scholars based in Germany, United States and Austria. W. E. Bachmann's co-authors include U Legler, E. L. Jenner, Wolfgang Rabl, Werner Reutter, H. Mehnert, Aǹdré S. Dreiding, Hanspeter Henninger, Erik Harms, Eberhard Standl and Anette‐Gabriele Ziegler and has published in prestigious journals such as Journal of the American Chemical Society, Diabetes Care and Biochemical Journal.

In The Last Decade

W. E. Bachmann

71 papers receiving 640 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. E. Bachmann Germany 15 236 185 137 123 122 78 707
H Tamaki Japan 18 46 0.2× 309 1.7× 168 1.2× 44 0.4× 93 0.8× 45 800
Tatsuya Maruyama Japan 16 69 0.3× 151 0.8× 261 1.9× 109 0.9× 32 0.3× 55 845
J Schlichtkrull Denmark 10 154 0.7× 393 2.1× 191 1.4× 21 0.2× 136 1.1× 14 701
R. C. Long United States 18 233 1.0× 108 0.6× 180 1.3× 97 0.8× 68 0.6× 34 623
Martin Wenzel Germany 15 68 0.3× 29 0.2× 147 1.1× 165 1.3× 31 0.3× 84 724
Minoru Aoki Japan 15 169 0.7× 46 0.2× 182 1.3× 63 0.5× 28 0.2× 75 730
Hideki Maeda Japan 17 85 0.4× 80 0.4× 490 3.6× 13 0.1× 39 0.3× 102 1.1k
Andrea Leone‐Bay United States 20 223 0.9× 89 0.5× 282 2.1× 123 1.0× 12 0.1× 43 1.0k
Uwe Gerlach Germany 19 96 0.4× 48 0.3× 802 5.9× 260 2.1× 33 0.3× 31 1.2k
Paul Wilson United States 13 118 0.5× 60 0.3× 491 3.6× 34 0.3× 124 1.0× 18 1.0k

Countries citing papers authored by W. E. Bachmann

Since Specialization
Citations

This map shows the geographic impact of W. E. Bachmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. E. Bachmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. E. Bachmann more than expected).

Fields of papers citing papers by W. E. Bachmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. E. Bachmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. E. Bachmann. The network helps show where W. E. Bachmann may publish in the future.

Co-authorship network of co-authors of W. E. Bachmann

This figure shows the co-authorship network connecting the top 25 collaborators of W. E. Bachmann. A scholar is included among the top collaborators of W. E. Bachmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. E. Bachmann. W. E. Bachmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hattenbach, Lars‐Olof, Peter Heinz, Nicolas Feltgen, et al.. (2021). Impact of the SARS-CoV-2 pandemic on ophthalmic care in Germany. Der Ophthalmologe. 118(Suppl 2). 166–175. 16 indexed citations
2.
Hoerauf, Hans, Thomas Ach, W. E. Bachmann, et al.. (2021). Gemeinsame Empfehlungen zur anästhesiologischen Versorgung in der Ophthalmochirurgie. Der Ophthalmologe. 118(9). 907–912. 3 indexed citations
3.
Hattenbach, Lars‐Olof, Peter Heinz, Nicolas Feltgen, et al.. (2020). Auswirkungen der SARS-CoV-2-Pandemie auf die ophthalmologische Versorgung in Deutschland. Der Ophthalmologe. 117(9). 892–904. 14 indexed citations
4.
Bachmann, W. E., et al.. (2008). Wirksamkeit der Kombinationsbehandlung mit Glibenclamid und Insulin bei Sulfonylharnstoff-Sekundärversagen: Kontrollierte multizentrische doppelblinde klinische Prüfung. DMW - Deutsche Medizinische Wochenschrift. 113(16). 631–636. 2 indexed citations
5.
Hasche, H, W. E. Bachmann, M. Haslbeck, & H Mehnert. (2008). Hypoglycaemia factitia: Drei Fallbeschreibungen. DMW - Deutsche Medizinische Wochenschrift. 107(16). 625–628. 1 indexed citations
6.
Thiel, H.‐J., et al.. (1990). Laserinduzierte Hornhautgefässokklusion bei variabler Emission und Absorption. Ophthalmologica. 201(3). 113–121. 2 indexed citations
7.
Bachmann, W. E.. (1988). Strategy for the primary and secondary prevention of occupational diseases in the German Democratic Republic.. Scandinavian Journal of Work Environment & Health. 14(5). 273–279. 1 indexed citations
8.
Bachmann, W. E., et al.. (1988). Die Kombinationstherapie Insulin/Sulfonylharnstoff in der Langzeittherapie des Typ-II-Diabetes nach „Sekundärversagen“. Journal of Molecular Medicine. 66(21). 1079–1084. 6 indexed citations
9.
10.
Bachmann, W. E., et al.. (1982). Human Insulin (recombinant DNA) in the Treatment of Patients with Newly Diagnosed Insulin-dependent Diabetes Mellitus (IDDM). Diabetes Care. 5(Supplement_2). 149–151. 2 indexed citations
11.
Bachmann, W. E., et al.. (1982). Efficiency of Human Insulin (recombinant DNA) in the Treatment of Diabetic Ketoacidosis and Severe Nonketoacidotic Hyperglycemia. Diabetes Care. 5(Supplement_2). 161–164. 3 indexed citations
12.
Bachmann, W. E., et al.. (1980). [Experimental studies on the physical therapy of sinusitis (author's transl)].. PubMed. 28(10). 352–5. 2 indexed citations
13.
Bachmann, W. E., I. Böttger, M. Haslbeck, & H. Mehnert. (1979). Extrapancreatic action of sulphonylureas: effect of gliquidone on insulin and glucagon binding to rat liver plasma membranes. European Journal of Clinical Investigation. 9(6). 411–415. 21 indexed citations
14.
Bachmann, W. E., et al.. (1978). [The clinical value of rhinomanometry. An analysis of the discrepancy between anamnesis, clinical state and rhinomanometry (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 57(5). 379–83. 3 indexed citations
15.
Bachmann, W. E.. (1978). [The technique and importance of examination of the function of the maxillary sinus ostium (author's transl)].. PubMed. 26(1). 25–7. 1 indexed citations
16.
Bachmann, W. E., et al.. (1976). The present status of rhinomanometry.. PubMed. 14(1). 5–9. 9 indexed citations
17.
Lesch, R, W. E. Bachmann, & Werner Reutter. (1973). THE ALTERATION OF THE REGENERATIVE ACTIVITY AND THE CELL CYCLE OF PARTIALLY HEPATECTOMIZED RAT LIVER FOLLOWING ADMINISTRATION OF d‐GALACTOSAMINE. Cell Proliferation. 6(3). 315–323. 4 indexed citations
18.
Bachmann, W. E., et al.. (1971). The Origins of Bowing and the Development of Bowed Instruments up to the Thirteenth Century. Notes. 28(1). 45–45. 2 indexed citations
19.
Bachmann, W. E.. (1962). Use of Motivation Research in Marketing. Studies in Business Policy, No. 97. National Industrial Board, Inc. $ 7.50 for ikke-medlemmer. (Forfattet af Dr. L. C. Lockley, University of Santa Clara), New York 1960,. 26. 2 indexed citations
20.
Bachmann, W. E., et al.. (1951). Reactions of 2-Arylcyclohexanones. V. 1-Phenylcyclohexaneethylamine, 1-Methyl-9-phenyl-Δ7-hexahydroindole and Related Compounds. Journal of the American Chemical Society. 73(1). 51–54. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H Tamaki Breakdown of academic impact, for papers by Tatsuya Maruyama Breakdown of academic impact, for papers by J Schlichtkrull Breakdown of academic impact, for papers by R. C. Long Breakdown of academic impact, for papers by Martin Wenzel Breakdown of academic impact, for papers by Minoru Aoki Breakdown of academic impact, for papers by Hideki Maeda Breakdown of academic impact, for papers by Andrea Leone‐Bay Breakdown of academic impact, for papers by Uwe Gerlach Breakdown of academic impact, for papers by Paul Wilson
Rankless by CCL
2026